Schedule 13G ownership disclosure
CALLIDITAS THERAPEUTICS AB
Security class unavailable · CUSIP: 13124Q106
Event date: 2020-06-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-20-001714
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Jun 08, 2020
- Reporting period
- Jun 05, 2020
- Description
- Schedule 13G beneficial ownership